Quick-Med Technologies, Inc., a life science company, develops proprietary technologies for the medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company develops Novel Intrinsically MicroBonded Utility Substrate (NIMBUS), a family of polymers that can be used in a range of applications, such as wound dressings and apparel; and MultiStat, a family of matrix metalloproteinase inhibitors that are used for the maintenance, healing, and repair of skin and eyes. Quick-Med Technologies was founded in 1997 and is headquartered in Gainesville, Florida.